Dr Ling Yang
Senior Epidemiologist; University Research Lecturer
- Clinical Trial Service Unit
Ling Yang qualified in Medicine at South-Eastern University, China, in 1995, then gained her MSc in Bio-statistics in 1998 at the same university, and her PhD in Epidemiology at the University of Tampere in Finland in 2005. Before moving to the University of Oxford in 2007, she worked at the Chinese Academy of Medical Science (CAMS) and Ministry of Health in Beijing (China), WHO International Agency for Research on Cancer in Lyon (IARC/WHO, France) and Karolinska Institute in Stockholm (Sweden). She is a Senior Epidemiologist at CTSU, University of Oxford, and also leads the Long-term Follow-up Working Group for the China Kadoorie Biobank study. Her main research focuses on women’s reproductive health, environmental causes of chronic diseases, especially cancer, based on big cohort studies, and evidence-based medicine using national survey data to provide strategies for chronic disease prevention and control in developing countries.
Patterns and trends of alcohol consumption in rural and urban areas of China: findings from the China Kadoorie Biobank.
Im PK. et al, (2019), BMC Public Health, 19
Central adiposity in relation to risk of liver cancer in Chinese adults: A prospective study of 0.5 million people.
Pang Y. et al, (2019), Int J Cancer
Tea consumption and bone health in Chinese adults: a population-based study.
Li X. et al, (2018), Osteoporos Int
Habitual Tea Consumption and Risk of Fracture in 0.5 Million Chinese Adults: A Prospective Cohort Study.
Shen Q. et al, (2018), Nutrients, 10
Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People.
Pang Y. et al, (2018), Hepatology, 68, 1308 - 1318